# Clinical Study to Determine Bioequivalence of Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Male Subjects Under Fasted Conditions

> **NCT07698275** · NA · COMPLETED · sponsor: **ADIUM** · enrollment: 34 (actual)

## Conditions studied

- Bioequivalance

## Interventions

- **DRUG:** TAMSULOSIN TEST
- **DRUG:** OMNIC OCAS REFERENCE

## Key facts

- **NCT ID:** NCT07698275
- **Lead sponsor:** ADIUM
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-01-12
- **Primary completion:** 2026-03-19
- **Final completion:** 2026-03-19
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07698275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07698275, "Clinical Study to Determine Bioequivalence of Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Male Subjects Under Fasted Conditions". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07698275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*